Welcome Guest | Register / Login

Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Acorda Therapeutics Inc - Key Facts
Acorda Therapeutics Inc - Key Employees
Acorda Therapeutics Inc - Key Employee Biographies
Acorda Therapeutics Inc - Major Products and Services
Acorda Therapeutics Inc - History
Acorda Therapeutics Inc - Company Statement
Acorda Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Acorda Therapeutics Inc - Business Description
Product Category: Ampyra
Overview
Performance
Product Category: Inbrija
Overview
Product Category: Qutenza
Overview
Performance
Product Category: Net Product Revenue
Capital Expenditure
Product Category: Royalty Revenue
Performance
R&D Overview
Acorda Therapeutics Inc - Corporate Strategy
Acorda Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Acorda Therapeutics Inc - Strengths
Acorda Therapeutics Inc - Weaknesses
Acorda Therapeutics Inc - Opportunities
Acorda Therapeutics Inc - Threats
Acorda Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company's Lifesciences Financial Deals and Alliances
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Acorda Therapeutics Inc, Recent Deals Summary
Section 5 - Company's Recent Developments
Jun 03, 2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson's at the 5th World Parkinson Congress
May 02, 2019: Acorda provides update for first quarter ended march 31, 2019
Mar 08, 2019: Acorda Therapeutics announces management changes
Feb 14, 2019: Acorda provides financial and pipeline update for fourth quarter and year end 2018
Feb 04, 2019: Acorda Therapeutics names Peter S. Carbone Senior Vice President, Quality
Jan 07, 2019: Acorda Provides 2018 highlights and 2019 guidance at J.P. Morgan Healthcare Conference
Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms
Dec 05, 2018: Acorda launches art initiative to foster better conversations about Parkinson's symptoms
Oct 31, 2018: Acorda provides financial and pipeline update for third quarter 2018
Aug 02, 2018: Acorda provides financial and pipeline update for second quarter 2018
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Acorda Therapeutics Inc, Key Facts
Acorda Therapeutics Inc, Key Employees
Acorda Therapeutics Inc, Key Employee Biographies
Acorda Therapeutics Inc, Major Products and Services
Acorda Therapeutics Inc, History
Acorda Therapeutics Inc, Other Locations
Acorda Therapeutics Inc, Subsidiaries
Acorda Therapeutics Inc, Key Competitors
Acorda Therapeutics Inc, Ratios based on current share price
Acorda Therapeutics Inc, Annual Ratios
Acorda Therapeutics Inc, Annual Ratios (Cont...1)
Acorda Therapeutics Inc, Annual Ratios (Cont...2)
Acorda Therapeutics Inc, Interim Ratios
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Acorda Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Acorda Therapeutics Inc, Performance Chart (2014 - 2018)
Acorda Therapeutics Inc, Ratio Charts
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy